Terms: = Leukemia AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Prognosis
53 results:
1. Demographic Disparities in Acute Myeloid leukemia Mortality Trends in the United States.
Doddi S; Salichs O; Hibshman T; Alamir P; Kunte S
Anticancer Res; 2024 May; 44(5):2211-2217. PubMed ID: 38677760
[TBL] [Abstract] [Full Text] [Related]
2. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
3. Immune checkpoint-related gene polymorphisms are associated with acute myeloid leukemia.
Wu Y; Li M; Meng G; Ma Y; Ye J; Sun T; Ji C
Cancer Med; 2023 Sep; 12(18):18588-18596. PubMed ID: 37602517
[TBL] [Abstract] [Full Text] [Related]
4. Polo-like kinase 1 Decrease During Induction Therapy Could Indicate Good Treatment Response, Favorable Risk Stratification, and Prolonged Survival in Pediatric Acute Lymphoblastic leukemia.
Zhao Y; Li C; Cai C; Fu H; Zhao Z; Han J; Zhang F; Wang J
J Pediatr Hematol Oncol; 2023 Aug; 45(6):e739-e745. PubMed ID: 36897339
[TBL] [Abstract] [Full Text] [Related]
5. Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract.
Wu H; Yu Z; Liu Y; Guo L; Teng L; Guo L; Liang L; Wang J; Gao J; Li R; Yang L; Nie X; Su D; Liang Z
Cancer Commun (Lond); 2022 Dec; 42(12):1367-1386. PubMed ID: 36264285
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic Significance of Long Non Coding RNA ANRIL and SNHG14 in Acute Myeloid leukemia.
Gamaleldin MA; Ghallab O; Abo Elwafa RA
Asian Pac J Cancer Prev; 2021 Dec; 22(12):3763-3771. PubMed ID: 34967554
[TBL] [Abstract] [Full Text] [Related]
7. Karyotypic complexity, TP53 pathogenic variants, and increased number of variants on Next-Generation Sequencing are associated with disease progression in a North American Adult T-Cell leukemia/Lymphoma cohort.
Zhang X; Shi Y; Ramesh KH; Naeem R; Wang Y
Int J Lab Hematol; 2021 Aug; 43(4):651-657. PubMed ID: 33988304
[TBL] [Abstract] [Full Text] [Related]
8. PreImplantation Factor immunohistochemical expression correlates with prostate cancer aggressiveness.
Raspollini MR; Montagnani I; Cirri P; Baroni G; Cimadamore A; Scarpelli M; Cheng L; Lopez-Beltran A; Montironi R; Barnea ER
Int J Biol Markers; 2020 Jun; 35(2):82-90. PubMed ID: 32389051
[TBL] [Abstract] [Full Text] [Related]
9. Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles.
Yan HHN; Siu HC; Ho SL; Yue SSK; Gao Y; Tsui WY; Chan D; Chan AS; Wong JWH; Man AHY; Lee BCH; Chan ASY; Chan AKW; Hui HS; Cheung AKL; Law WL; Lo OSH; Yuen ST; Clevers H; Leung SY
Gut; 2020 Dec; 69(12):2165-2179. PubMed ID: 32217638
[TBL] [Abstract] [Full Text] [Related]
10. Increased Risk of Acute Myelogenous leukemia After Early Onset but Not Late-Onset Colorectal Cancer.
Lehrer S; Rheinstein PH
Am J Clin Oncol; 2020 Apr; 43(4):263-269. PubMed ID: 31876540
[TBL] [Abstract] [Full Text] [Related]
11. Akt2 mediates glucocorticoid resistance in lymphoid malignancies through FoxO3a/Bim axis and serves as a direct target for resistance reversal.
Xie M; Yang A; Ma J; Wu M; Xu H; Wu K; Jin Y; Xie Y
Cell Death Dis; 2019 Jan; 9(10):1013. PubMed ID: 30598523
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics.
Khan M; Loree JM; Advani SM; Ning J; Li W; Pereira AAL; Lam M; Raghav K; Morris VK; Broaddus R; Maru D; Overman MJ; Kopetz S
Clin Colorectal Cancer; 2018 Dec; 17(4):e699-e709. PubMed ID: 30205948
[TBL] [Abstract] [Full Text] [Related]
13. Early BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML alliance.
Zhang J; Wang Y; Wang J; Hu J; Chen S; Jin J; Liu T; Zhou J; Hu Y; Ma D; Huang X; Ji C; Hou M
Blood Cancer J; 2018 Jun; 8(7):61. PubMed ID: 29915172
[TBL] [Abstract] [Full Text] [Related]
14. HPV infection and p16
Missaoui N; Mestiri S; Bdioui A; Zahmoul T; Hamchi H; Mokni M; Hmissa S
Pathol Res Pract; 2018 Apr; 214(4):498-506. PubMed ID: 29572122
[TBL] [Abstract] [Full Text] [Related]
15. Initial flow cytometric evaluation of the Clearllab lymphoid screen.
Hedley BD; Cheng G; Luider J; Kern W; Lozanski G; Chin-Yee I; Lowes LE; Keeney M; Careaga D; Magari R; Tejidor L
Cytometry B Clin Cytom; 2018 Sep; 94(5):707-713. PubMed ID: 29171939
[TBL] [Abstract] [Full Text] [Related]
16. Proteasome inhibition enhances the efficacy of volasertib-induced mitotic arrest in AML in vitro and prolongs survival in vivo.
Schnerch D; Schüler J; Follo M; Felthaus J; Wider D; Klingner K; Greil C; Duyster J; Engelhardt M; Wäsch R
Oncotarget; 2017 Mar; 8(13):21153-21166. PubMed ID: 28416751
[TBL] [Abstract] [Full Text] [Related]
17. [Granulocytic Sarcoma: Two cases with Lymph Node Presentation].
Russo MP; Andresik D; Perusini MA
Rev Fac Cien Med Univ Nac Cordoba; 2016; 73(3):202-204. PubMed ID: 27805558
[TBL] [Abstract] [Full Text] [Related]
18. Additional chromosomal abnormalities in core-binding factor acute myeloid leukemia.
Hsiao HH; Liu YC; Wang HC; Tsai YF; Wu CH; Cho SF; Hsu JF; Huang CT; Hsiao SY; Lee CP; Chang CS; Lin SF; Liu TC
Genet Mol Res; 2015 Dec; 14(4):17028-33. PubMed ID: 26681050
[TBL] [Abstract] [Full Text] [Related]
19. High constitutive Akt2 activity in U937 promonocytes: effective reduction of Akt2 phosphorylation by the histamine H2-receptor and the β2-adrenergic receptor.
Werner K; Neumann D; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jan; 389(1):87-101. PubMed ID: 26475619
[TBL] [Abstract] [Full Text] [Related]
20. Idelalisib: First-in-Class PI3K Delta Inhibitor for the Treatment of Chronic Lymphocytic leukemia, Small Lymphocytic leukemia, and Follicular Lymphoma.
Yang Q; Modi P; Newcomb T; Quéva C; Gandhi V
Clin Cancer Res; 2015 Apr; 21(7):1537-42. PubMed ID: 25670221
[TBL] [Abstract] [Full Text] [Related]
[Next]
